Agios Pharmaceuticals, Inc.
AGIONASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $2.20B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $22.24$46.00
- Volume (live)
- -
- Avg. volume (3M)
- 1.17M
Agios Pharmaceuticals (AGIO) Stock Price & Financial Analysis
Agios Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $36.10 - $37.32 |
|---|---|
| 52-Week High | $46.00 |
| 52-Week Low | $22.24 |
| Open | $36.93 |
| Volume (last close) | 920.04K |
| Average Volume (3M) | 1.17M |
| Revenue (TTM) | 98.34M |
|---|---|
| Net Income (TTM) | -411.29M |
| Free Cash Flow (TTM) | -365.25M |
| EPS (TTM) | −$7.01 |
| Profit Margin | -418.24% |
| Operating Margin | -466.78% |
| Return on Equity (ROE) | -40.09% |
| Debt to Equity | 0.03 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 2.20B |
|---|---|
| Shares Outstanding | 59.49M |
| Price to Sales (P/S) | 22.38 |
| Price to Book (P/B) | 2.15 |
| EV/EBITDA | -5.01 |
| 50-Day MA | $33.20 |
|---|---|
| 200-Day MA | $31.36 |
| 1-Year Change | −11.64% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Agios Pharmaceuticals at a Glance
As of the Oct 23, 2026 close, Agios Pharmaceuticals (AGIO) has a market capitalization of $2.20B. The stock trades at 22.4× sales. Over the trailing twelve months it lost $411.29M on revenue of $98.34M and burned $365.25M of free cash flow. Revenue grew 140.6% year over year.
As of its latest reported balance sheet, it holds $99.65M in cash and securities against $31.17M of debt, a net cash position of $68.48M.
Agios Pharmaceuticals does not currently pay a dividend.
The share price is down 11.6% over the past year. At $37.00 (the Oct 23, 2026 close) it sits within its 52-week range of $22.24 to $46.00, above its 200-day moving average of $31.36.
Based on 7 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $45.20, 22.2% above the Oct 23, 2026 close.
Frequently Asked Questions About Agios Pharmaceuticals
What is the current stock price for AGIO?
As of the Oct 23, 2026 close, AGIO stock trades at $37.00. The 52-week range is $22.24–$46.00, with a day range of $36.10–$37.32.
What is the P/E ratio for AGIO?
The P/E ratio (Price-to-Earnings) for AGIO is shown in the Key Statistics section. This valuation metric helps compare Agios Pharmaceuticals, Inc. to industry peers.
Does AGIO pay dividends?
Agios Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for AGIO?
Based on ratings from 7 professional analysts over the last 90 days, the consensus for AGIO is Buy. The average 12-month price target is $45.20, a 22.2% upside from the Oct 23, 2026 close of $37.00.
What is the market cap of AGIO?
As of the Oct 23, 2026 close, Agios Pharmaceuticals's market capitalization is $2.20B, classifying it as a mid-cap company. Agios Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.